Solid Organ Transplantation (SOT) MarketBy Organ-
Solid Organ Transplantation (SOT) MarketBy Treatment-
Solid Organ Transplantation (SOT) MarketBy End User-
Solid Organ Transplantation (SOT) MarketBy Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Solid Organ Transplantation (SOT) Market Snapshot
Chapter 4. Global Solid Organ Transplantation (SOT) Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Organ Estimates & Trend Analysis
5.1. by Organ & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Organ:
5.2.1. Renal
5.2.2. Liver
5.2.3. Heart
5.2.4. Lung
5.2.5. Pancreatic
5.2.6. Intestinal Transplantation
5.2.7. Others
Chapter 6. Market Segmentation 2: by Treatment Estimates & Trend Analysis
6.1. by Treatment & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Treatment:
6.2.1. Immunosuppressive
6.2.2. Monoclonal Antibodies
6.2.3. Others
Chapter 7. Market Segmentation 3: by End-Users Estimates & Trend Analysis
7.1. by End-Users & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-Users:
7.2.1. Hospitals
7.2.2. Homecare
7.2.3. Specialty Centers
7.2.4. Others
Chapter 8. Solid Organ Transplantation (SOT) Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Organ, 2024-2031
8.1.2. North America Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
8.1.3. North America Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by End-Users, 2024-2031
8.1.4. North America Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.2. Europe
8.2.1. Europe Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Organ, 2024-2031
8.2.2. Europe Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
8.2.3. Europe Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by End-Users, 2024-2031
8.2.4. Europe Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Organ, 2024-2031
8.3.2. Asia Pacific Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
8.3.3. Asia-Pacific Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by End-Users, 2024-2031
8.3.4. Asia Pacific Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.4. Latin America
8.4.1. Latin America Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Organ, 2024-2031
8.4.2. Latin America Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
8.4.3. Latin America Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by End-Users, 2024-2031
8.4.4. Latin America Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Organ, 2024-2031
8.5.2. Middle East & Africa Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by Treatment, 2024-2031
8.5.3. Middle East & Africa Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by End-Users, 2024-2031
8.5.4. Middle East & Africa Solid Organ Transplantation (SOT) Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Teva Pharmaceutical Industries Ltd
9.2.2. Mylan N.V
9.2.3. Johnsons & Johnsons Services Inc
9.2.4. F. Hoffman-La Roche Ltd.
9.2.5. Lilly
9.2.6. Merck & Co., Inc.
9.2.7. Aurobindo Pharma
9.2.8. Bristol-Myers Squibb Company
9.2.9. GSK plc
9.2.10. Ascendis Pharma A/S
9.2.11. LEO Pharma A/S
9.2.12. Genentech, Inc
9.2.13. CAREDX
9.2.14. Glycorex Transplantation AB
9.2.15. DaVita Inc.
9.2.16. Celltrion Inc
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.